GlucoTrack, Inc. GCTK
0.40 USD 0.00 (+0.00%)
Nov 4, 2026, 3:42 PM EST
Day range unavailable
0.342 52-week range 207.00
- YTD
- -99.66%
- 1 year
- -99.78%
- Market cap
- 473.65K
- EPS (ttm)
- -246.30
- Shares out
- 14.49M
- YTD return
- -99.66%
- 1-year return
- -99.78%
- Avg volume
- 1.87M
- Previous close
- 0.40
- 52-week range
- 0.342 – 207.00
- Beta
- 0.16
1m -0.0402 (-9.13%)
Key statistics
- Enterprise value
- 1.60M
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 0.35
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Revenue growth
- 0.00%
- Free cash flow
- -4.69M
- Total cash
- 159.00K
- Total debt
- 274.00K
- Return on equity
- -541.13%
- Short % of float
- 0.83%
- 50-day average
- 0.97332
- 200-day average
- 1.89
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
GCTK Revenue — quarterly 0
GCTK Net income — quarterly -3.81M
GCTK EPS — quarterly -22.80
About GlucoTrack, Inc.
GlucoTrack, Inc., a medical device company, focused on the design, development, and commercialization of novel technologies for people with diabetes in the United States. It develops GlucoTrack, a noninvasive glucose monitoring device that helps people with diabetes and pre-diabetics to obtain blood glucose level readings without the pain. The company was formerly known as Integrity Applications, Inc. and changed its name to GlucoTrack, Inc. in November 2021. GlucoTrack, Inc. was founded in 2001 and is based in Rutherford, New Jersey.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Country
- United States
- Website
- glucotrack.com
News
12 Health Care Stocks Moving In Monday's Intraday Session 
12 Health Care Stocks Moving In Thursday's After-Market Session 
Glucotrack’s Subsidiary Lōkahi Therapeutics Unveils Qare Comparative Health Platform For GLP-1 And Other Treatment Outcomes - 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Friday's Pre-Market Session
12 Health Care Stocks Moving In Thursday's Intraday Session - 12 Health Care Stocks Moving In Thursday's Pre-Market Session
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket 
Glucotrack Stock Is Trending: Here's Why GCTK Jumped Over 80% After Hours - 12 Health Care Stocks Moving In Wednesday's After-Market Session
Your note
Sign in to keep a note on GCTK — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| SYCOFF ANDREW | Director and Beneficial Owner of more than 10% of a Class of Security | Purchase | Apr 21, 2024 | 2,951,260 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.47% | 27,161 | 7.17K | Sep 29, 2024 |
| Alerus Financial NA | 0.24% | 13,855 | 3.66K | Sep 29, 2024 |
| Cetera Investment Advisers | 0.17% | 10,000 | 2.64K | Sep 29, 2024 |
| UBS Group AG | 0.05% | 3,085 | 814 | Sep 29, 2024 |
| Tower Research Capital LLC (TRC) | 0.01% | 432 | 114 | Sep 29, 2024 |
| Morgan Stanley | 0.01% | 500 | 131 | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.37% | 21,613 | 5.71K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.09% | 5,064 | 1.34K | Oct 30, 2024 |